Mine Safety and Health Research Advisory Committee: Notice of Charter Renewal, 78800-78801 [E8-30487]

Download as PDF 78800 Federal Register / Vol. 73, No. 247 / Tuesday, December 23, 2008 / Notices foreign banks, and Edge and agreement corporations. Annual reporting hours: 59,902 hours. Estimated average hours per response: Initial terms disclosure, 1.5 minutes; change in terms disclosure, 1 minute; periodic disclosure, 7 hours; and error resolution rules, 30 minutes. Number of respondents: 1,205. General description of report: This information collection is mandatory (15 U.S.C. 1693 et seq.). The disclosures required by the rule and information about error allegations and their resolution are confidential between the institution and the consumer. Since the Federal Reserve does not collect any information, no issue of confidentiality arises. However, the information, if made available to the Federal Reserve, may be protected from disclosure under exemptions (b)(4), (6), and (8) of the Freedom of Information Act (5 U.S.C. 552(b)(4), (6), and (8)). Abstract: The Electronic Funds Transfer Act and Regulation E are designed to ensure adequate disclosure of basic terms, costs, and rights relating to electronic fund transfer (EFT) services provided to consumers. Institutions offering EFT services must disclose to consumers certain information, including: initial and updated EFT terms, transaction information, periodic statements of activity, the consumer’s potential liability for unauthorized transfers, and error resolution rights and procedures. EFT services include automated teller machines, telephone bill payment; point-of-sale transfers in retail stores, fund transfers initiated through the internet, and preauthorized transfers to or from a consumer’s account. Current Actions: On October 15, 2008, the Federal Reserve published a notice in the Federal Register (73 FR 61126) requesting public comment for 60 days on the extension, without revision, of this information collection. The comment period for this notice expired on December 15, 2008. The Federal Reserve did not receive any comments. Board of Governors of the Federal Reserve System, dated December 18, 2009. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E8–30493 Filed 12–22–08; 8:45 am] BILLING CODE 6210–01–P VerDate Aug<31>2005 16:29 Dec 22, 2008 Jkt 217001 GENERAL SERVICES ADMINISTRATION [OMB Control No. 3090–0204] General Services Administration Acquisition Regulation; Information Collection; Commercial Delivery Schedule Clause and Notice of Shipment AGENCY: Office of the Chief Acquisition Officer, GSA. ACTION: Notice of request for comments regarding a renewal to an existing OMB clearance. SUMMARY: Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35), the General Services Administration will be submitting to the Office of Management and Budget (OMB) a request to review and approve an extension of a currently approved information collection requirement regarding commercial delivery schedule clause and notice of shipment. The clearance currently expires on December 31, 2008. Public comments are particularly invited on: Whether this collection of information is necessary and whether it will have practical utility; whether our estimate of the public burden of this collection of information is accurate and based on valid assumptions and methodology; and ways to enhance the quality, utility, and clarity of the information to be collected. DATES: Submit comments on or before: February 23, 2009. FOR FURTHER INFORMATION CONTACT: Suzanne Neurauter, Procurement Analyst, Contract Policy Division, at telephone (202) 219–0310 or via e-mail to suzanne.neurauter@gsa.gov. ADDRESSES: Submit comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to the Regulatory Secretariat (VPR), General Services Administration, Room 4041, 1800 F Street, NW., Washington, DC 20405. Please cite OMB Control No. 3090–0204, Commercial Delivery Schedule Clause and Notice of Shipment, in all correspondence. SUPPLEMENTARY INFORMATION: A. Purpose The Commercial Delivery Schedule (Multiple Award Schedule) clause required offerors to provide their commercial delivery terms and conditions. FSS awards contracts to commercial firms under terms and conditions that mirror commercial practices for the supplies and services. In order to ensure the Government PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 obtains the supplies within the offeror’s commercial delivery timeframe, the offeror must provide the information requested in the GSAR clause, Commercial Delivery Schedule (Multiple Award Schedule). Such a notice is necessary when preparations need to be made for docking arrangements, storage, trans-shipment of materials handling equipment of supplies and equipment upon delivery, labor and inside delivery at destination. B. Annual Reporting Burden Total Responses annually: 10,305. Hours Per Response: .26. Total Burden Hours: 2741. Obtaining Copies of Proposals: Requesters may obtain a copy of the information collection documents from the General Services Administration, Regulatory Secretariat (VPR), 1800 F Street, NW., Room 4041, Washington, DC 20405, telephone (202) 501–4225. Please cite OMB Control No. 3090–0204, Commercial Delivery Schedule Clause and Notice of Shipment, in all correspondence. Dated: December 18, 2008. Al Matera, Director, Office of Acquisition Policy. [FR Doc. E8–30504 Filed 12–22–08; 8:45 am] BILLING CODE 6820–61–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Mine Safety and Health Research Advisory Committee: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Mine Safety and Health Research Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through November 30, 2010. For information, contact Jeffrey Kohler, Ph.D., Executive Secretary, Mine Safety and Health Research Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services, 626 Cochrans Mill Road, Mailstop P05, Pittsburgh, Pennsylvania 15236, Telephone (412) 386–5301 or fax (412) 386–5300. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee E:\FR\FM\23DEN1.SGM 23DEN1 Federal Register / Vol. 73, No. 247 / Tuesday, December 23, 2008 / Notices management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: December 15, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–30487 Filed 12–22–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, Coordinating Center for Health Promotion (BSC, CCHP) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Times and Dates: 1 p.m.–5 p.m., January 14, 2009; 8:30 a.m.–3:30 p.m., January 15, 2009. Place: CDC, 1825 Century Boulevard, NE., Century Center Building 2400, Room 1042, Atlanta, Georgia 30345. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: This BSC is charged with providing advice and guidance to the Secretary of Health and Human Services, the Director of CDC, and the Director of CCHP concerning strategies and goals for the programs and research within the National Center on Birth Defects and Developmental Disabilities and the National Center for Chronic Disease Prevention and Health Promotion. Matters To Be Discussed: The agenda will include an introduction to the federal advisory committee process for new members; an overview of the CDC, CCHP, and the national centers; and a discussion of the secondary review process. Agenda items are subject to change as priorities dictate. Providing Oral or Written Comments: It is the policy of the BSC, CCHP to accept written public comments and provide a brief period for oral public comments. Oral Comments: In general, each individual or group requesting to make an oral presentation will be limited to a total time of five minutes (unless otherwise indicated). Speakers must also submit their comments in writing for inclusion in the meeting’s Summary Report. To ensure adequate time is scheduled for public comments, individuals or groups planning to make an oral presentation should, when possible, notify the contact person below at least one week prior to the meeting date. Written Comments: For individuals or groups unable to attend the meeting, the CCHP BSC accepts written VerDate Aug<31>2005 16:29 Dec 22, 2008 Jkt 217001 comments until the date of the meeting (unless otherwise stated). However, the comments should be received at least one week prior to the meeting date so that the comments may be made available to the BSC for their consideration and public distribution. Written comments, one hard copy with original signature, should be provided to the contact person below. Written comments will be included in the meeting’s Summary Report. Contact Person for Additional Information: Karen Steinberg, PhD, Senior Science Officer, Coordinating Center for Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop E– 70, Atlanta, Georgia 30341; telephone (404) 498–6700; fax (404) 498–6880; or via e-mail at Karen.Steinberg@cdc.hhs.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for CDC and the Agency for Toxic Substances and Disease Registry. Dated: December 12, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–30486 Filed 12–22–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Clinical Laboratory Improvement Advisory Committee, (CLIAC) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: Times and Dates: 8:30 a.m.–5 p.m., February 4, 2009, 8:30 a.m.–3:30 p.m., February 5, 2009. Place: CDC, 1600 Clifton Road, NE., Tom Harkin Global Communications Center, Building 19, Room 232, Auditorium B, Atlanta, Georgia 30333. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This Committee is charged with providing scientific and technical advice and guidance to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the need for, and the nature of, revisions to the standards under which clinical laboratories are regulated; the impact on medical and laboratory practice of proposed revisions to the standards; and the modification of the standards to accommodate technological advances. Matters To Be Discussed: The agenda will include updates from the CDC, the Centers for Medicare & Medicaid Services, and the PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 78801 Food and Drug Administration; and presentations and discussions addressing studies and evaluation of laboratory practices and standards. Agenda items are subject to change as priorities dictate. New Information—Online Registration Required: In order to expedite security clearance process at the CDC Roybal Campus located on Clifton Road, all CLIAC attendees are required to register for the meeting online at least 14 days in advance at http:// wwwn.cdc.gov/cliac/default.aspx by clicking the ‘‘Register for a Meeting’’ link and completing all forms according to the instructions given. Please complete all the required fields before submitting your registration and submit no later than January 21, 2009. Providing Oral or Written Comments: It is the policy of CLIAC to accept written public comments and provide a brief period for oral public comments whenever possible. Oral Comments: In general, each individual or group requesting to make an oral presentation will be limited to a total time of five minutes (unless otherwise indicated). Speakers must also submit their comments in writing for inclusion in the meeting’s Summary Report. To assure adequate time is scheduled for public comments, individuals or groups planning to make an oral presentation should, when possible, notify the contact person below at least one week prior to the meeting date. Written Comments: For individuals or groups unable to attend the meeting, CLIAC accepts written comments until the date of the meeting (unless otherwise stated). However, the comments should be received at least one week prior to the meeting date so that the comments may be made available to the Committee for their consideration and public distribution. Written comments, one hard copy with original signature, should be provided to the contact person below. Written comments will be included in the meeting’s Summary Report. Contact Person for Additional Information: Nancy Anderson, Chief, Laboratory Practice Standards Branch, Division of Laboratory Systems, National Center for Preparedness, Detection, and Control of Infectious Diseases, Coordinating Center for Infectious Diseases, CDC, 1600 Clifton Road, NE., Mailstop F–11, Atlanta, Georgia 30333; telephone (404) 498– 2741; fax (404) 498–2219; or via e-mail at Nancy.Anderson@cdc.hhs.gov The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for CDC and the Agency for Toxic Substances and Disease Registry. Dated: December 15, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–30485 Filed 12–22–08; 8:45 am] BILLING CODE 4163–18–P E:\FR\FM\23DEN1.SGM 23DEN1

Agencies

[Federal Register Volume 73, Number 247 (Tuesday, December 23, 2008)]
[Notices]
[Pages 78800-78801]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-30487]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Mine Safety and Health Research Advisory Committee: Notice of 
Charter Renewal

    This gives notice under the Federal Advisory Committee Act (Pub. L. 
92-463) of October 6, 1972, that the Mine Safety and Health Research 
Advisory Committee, Centers for Disease Control and Prevention, 
Department of Health and Human Services, has been renewed for a 2-year 
period through November 30, 2010.
    For information, contact Jeffrey Kohler, Ph.D., Executive 
Secretary, Mine Safety and Health Research Advisory Committee, Centers 
for Disease Control and Prevention, Department of Health and Human 
Services, 626 Cochrans Mill Road, Mailstop P05, Pittsburgh, 
Pennsylvania 15236, Telephone (412) 386-5301 or fax (412) 386-5300.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee

[[Page 78801]]

management activities, for both CDC and the Agency for Toxic Substances 
and Disease Registry.

    Dated: December 15, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-30487 Filed 12-22-08; 8:45 am]
BILLING CODE 4163-18-P